miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK
Oncology Research · 2024
DOI: 10.32604/or.2023.042581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Xiaoxi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianshui First People's Hospital, Tianshui, China. Hauptthemen laut MEDLINE: Adenoma, Apoptosis, Gene Expression Regulation, Neoplastic, GPI-Linked Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
MicroRNA (miR)-200b-3p has been associated with many tumors, but its involvement in pituitary adenoma is unclear. This study investigated the molecular mechanism underlying miR-200b-3p regulation in pituitary adenomas to provide a theoretical basis for treatment. Bioinformatics was used to analyze pituitary adenoma-related genes and screen new targets related to RECK and miRNA. As well, the relationship between miR-200b-3p and RECK protein was verified using a double-luciferase reporter gene assay. The expression of miR-200b-3p in clinical samples was analyzed by in situ hybridization. Transfection of the miR-200b-3p inhibitor and small interfering-RECK (si-RECK) was verified by qPCR. GH3 cell viability and proliferation were detected using CCK8 and EdU assays. Apoptosis was detected by flow cytometry and western blotting. Wound healing and Transwell assays were used to detect cell migration and invasion. The effects of miR-200b-3p and RECK on GH3 cells were verified using salvage experiments. miR-200b-3p was highly expressed in pituitary tumor tissue. Inhibitors of miR-200b-3p inhibited cell proliferation promoted cell apoptosis, inhibited invasion and migration, and inhibited the expression of matrix metalloproteinases. Interestingly, miR-200b-3p negatively regulated RECK. The expression of RECK in pituitary adenoma tissues was lower than that in neighboring tissues. Si-RECK rescued the function of miR-200b-3p inhibitors in the above cellular behaviors, and miR-200b-3p accelerated the development of pituitary adenoma by negatively regulating RECK expression. In summary, this study investigated the molecular mechanism by which miR-200b-3p regulates the progression of pituitary adenoma through the negative regulation of RECK. The findings provide a new target for the treatment of pituitary adenoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tianshui First People's Hospital, Tianshui, China.
- Department of Neurosurgery, The Second Affiliated Hospital of Lanzhou University, Lanzhou, China.
Zitieren
APA
Wang, X., Jia, Y., Li, Q., Yang, Q., Liu, Y., Wei, B., Niu, X., Zhang, Y., Luo, X., Zhao, Z., & Wang, P. (2024). miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK. Oncology Research. https://doi.org/10.32604/or.2023.042581
Vancouver
Wang X, Jia Y, Li Q, Yang Q, Liu Y, Wei B, et al. miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK. Oncology Research. 2024. doi:10.32604/or.2023.042581
BibTeX
@article{Wang2024,
author = {Wang, Xiaoxi and Jia, Yanfei and Li, Qiang and Yang, Qiang and Liu, Yingfeng and Wei, Beifeng and Niu, Xiang and Zhang, Yinjie and Luo, Xiaodong and Zhao, Ziyu and Wang, Peng},
title = {miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK},
journal = {Oncology Research},
year = {2024},
doi = {10.32604/or.2023.042581}
}
EUVIMED